Patents by Inventor Bennett DAVIS

Bennett DAVIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10899840
    Abstract: The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a selective 4-1 BB agonist, and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that express PD-L1.
    Type: Grant
    Filed: February 3, 2015
    Date of Patent: January 26, 2021
    Assignees: Pfizer Inc., Merck Sharp & Dohme Corp.
    Inventors: Craig Bennett Davis, Maria Theresa Koehler, Li Yan
  • Publication number: 20170174773
    Abstract: The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a selective 4-1 BB agonist, and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that express PD-L1.
    Type: Application
    Filed: February 3, 2015
    Publication date: June 22, 2017
    Inventors: Craig Bennett Davis, Maria Theresa Koehler, Li Yan
  • Publication number: 20110166935
    Abstract: The present invention provides systems for analyzing URL lookup requests that are malformed or otherwise fail to provide an adequate response, and providing content-relevant results for those requests. The systems and methods rely on analysis of URL requests and on logical assumptions based on common errors in submission of URL requests. A weighting system is applied to portions of failed lookup terms to provide improved relevancy for results based on those failed lookup terms.
    Type: Application
    Filed: March 15, 2011
    Publication date: July 7, 2011
    Applicant: PAXFIRE, INC.
    Inventors: Douglas ARMENTROUT, Bennett DAVIS